Mithra Pharma Files for Bankruptcy, Continues Richter Talks

June 10, 2024, 5:26 PM UTC

Mithra announced the opening of the bankruptcy procedure of Mithra Pharmaceuticals.

  • Mithra Pharmaceuticals continues negotiations with Gedeon Richter relating to the sale of all shares in Neuralis and Estetra held by Mithra Pharmaceuticals and specific assets of Mithra R&D relating to the manufacture of estetrol
  • Deal with Richter is expected to be signed and completed as soon as reasonably possible
  • Transaction won’t create any value for Mithra Pharmaceuticals holders
  • Mithra CDMO and Novalon entities aren’t affected by the bankruptcy
    • They are subject to separate reorganization proceedings, which should be extended until June 30, subject to court approval
  • NOTE: June 4, ...





Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.